Polygala tenuifolia polysaccharide (PTP) inhibits cell proliferation by repressing Bmi-1 expression and downregulating telomerase activity

Tumor Biology

Volumn 36, Issue 4, 2015, Pages 2907-2912

  Zhang, Fubin ^a,b,c   Song, Xiaowei ^a,b,c   Li, Li ^a,b,c   Wang, Jingfang ^a,b,c   Lin, Leyuan ^a,b,c   Li, Cong ^a,b,c   Li, Hongtao ^a,b,c   Lv, Yanju ^a,b,c   Jin, Yinghua ^a,b,c   Liu, Ying ^a,b,c   Hu, Yu ^a,b,c   Xin, Tao ^a,b,c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Anesthesiology Department   (China)

^c MAYO CLINIC   (United States)

Author keywords

Antitumor; Bmi 1; Human ovarian cancer; Polygala tenuifolia; Polysaccharide; Telomerase

Indexed keywords

BMI1 PROTEIN; BMI1 PROTEIN, HUMAN; POLYSACCHARIDE; TELOMERASE;

BIOSYNTHESIS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; OVARIAN NEOPLASMS; PATHOLOGY; POLYGALA; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; POLYCOMB REPRESSIVE COMPLEX 1; POLYGALA; POLYSACCHARIDES; TELOMERASE;

EID: 84936753275     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2920-y     Document Type: Article

References (29)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol. 2005;20:207–25.
2. Guppy AE, Nathan PD, Rustin GJ. Epithelial ovarian cancer: a review of current management. Clin Oncol (R Coll Radiol). 2005;17:399–411.
3. Badgwell D, Bast RJ. Early detection of ovarian cancer. Dis Markers. 2007;23:397–410.
4. Bast Jr RC, Brewer M, Zou C, Hernandez MA, Daley M, Ozols R, et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res. 2007;174:91–100.
5. Silva JS, Moura MD, Oliveira RA, Diniz MF, Barbosa-Filho JM. Natural product inhibitors of ovarian neoplasia. Phytomedicine. 2003;10:221–32.
6. Brewer MA, Johoson K, Follen M, Gershenson D, Bast Jr R. Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res. 2003;9:20–30.
7. Westfall SD, Nilsson EE, Skinner MK. Role of triptolide as an adjunct chemotherapy for ovarian cancer. Chemotherapy. 2008;54:67–76.
8. Carr C, Ng J, Wigmore T. The side effects of chemotherapeutic agents. Curr Anaesth Crit Care. 2008;19:70–9.
9. Kim E, Rye PT, Essigmann JM, Croy RG. A bifunctional platinum (II) antitumor agent that forms DNA adducts with affinity for the estrogen receptor. J Inorg Biochem. 2009;103:256–61.
10. Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D. Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst. 2000;92:42–7.
11. Cui Y, Shu XO, Gao Y, Wen W, Ruan ZX, Jin F, et al. Use of complementary and alternative medicine by Chinese women with breast cancer. Breast Cancer Res Treat. 2004;85:263–70.
12. Powell CB, Dibble SL, Dall’Era JE, Cohen I. Use of herbs in women diagnosed with ovarian cancer. Int J Gynecol Cancer. 2002;12:214–7.
13. Wirth JH, Hudgins JC, Paice JA. Use of herbal therapies to relieve pain: a review of adverse effects. Pain Manag Nurs. 2005;6:145–67.
14. Zhu W, Huang L, Xu X, Qian H, Xu W. Anti-proliferation effect of BMI-1 in U937 cells with siRNA. Int J Mol Med. 2010;25:889–95.
15. Becker M, Korn C, Sienerth AR, Voswinckel R, Luetkenhaus K, Ceteci F, et al. Polycomb group protein Bmi1 is required for growth of RAF driven non-small-cell lung cancer. PLoS One. 2009;4:4230.
16. Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T, et al. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol. 2005;82:42–7.
17. Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res. 2001;61:2409–12.
18. Kim JH, Yoon SY, Jeong SH, Kim SY, Moon SK, Joo JH. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer. Breast. 2004;13:383–8.
19. Kim JH, Yoon SY, Kim CN, Joo JH, Moon SK, Choe IS, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/p14ARF proteins. Cancer Lett. 2004;203:217–24.
20. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res. 2006;66:6225–32.
21. Mihic-Probst D, Kuster A, Kilgus S, Bode-Lesniewska B, Ingold-Heppner B, Leung C, et al. Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma. Int J Cancer. 2007;121:1764–70.
22. Kang MK, Kim RH, Kim SJ, Yip FK, Shin KH, Dimri GP, et al. Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer. 2007;96:126–33.
23. Glinsky GV, Berezovska O, Glinskii AB. Microarray analysis identifies a death from cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 2005;115:1503–21.
24. Zhang F, Sui L, Xin T. Correlations of BMI-1 expression and telomerase activity in ovarian cancer tissues. Exp Oncol. 2008;30:70–4.
25. Berezovska OP. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle. 2006;5:1886–901.
26. Huang ST, Wang CY, Yang RC, Chu CJ, Wu HT, Pang JH. Wogonin, an active compound in Scutellaria baicalensis, induces apoptosis and reduces telomerase activity in the HL-60 leukemia cells. Phytomedicine. 2010;17:47–54.
27. Park SE, Park C, Kim SH, Hossain MA, Kim MY, Chung HY, et al. Korean red ginseng extract induces apoptosis and decreases telomerase activity in human leukemia cells. J Ethnopharmacol. 2009;121:304–12.
28. Xin T, Zhang FB, Sui GJ, Jin XM. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity. Br J Biomed Sci. 2012;6:62–6.
29. Xin T, Zhang F, Jiang Q, Chen C, Huang D, Li Y, et al. Extraction, purification and antitumor activity of a water-soluble polysaccharide from the roots of Polygala tenuifolia. Carbohydr Polym. 2012;90:1127–31.